PRISM BioLab

company

About

PRISM develop therapeutic drugs that cure these intractable diseases using our unique peptide mimic technology.

  • 11 - 50

Details

Last Funding Type
Series C
Last Funding Money Raised
¥1.40B
Industries
Biopharma,Biotechnology,Pharmaceutical,Therapeutics
Founded date
Nov 2, 2006
Number Of Employee
11 - 50
Operating Status
Active

PRISM provider of a therapeutic treatment for non-oncology indications.The company develops therapeutic agents that are used to cure pulmonary fibrosis, cancer and incurable diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥1.40B
PRISM BioLab has raised a total of ¥1.40B in funding over 2 rounds. Their latest funding was raised on Jun 13, 2013 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 13, 2013 Series C ¥1.40B 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
PRISM BioLab is funded by 2 investors. CollaboSGK and Angel Capital are the most recent investors.
Investor Name Lead Investor Funding Round
CollaboSGK Series C
Angel Capital Series C